- Home
- BHC vs LMAT Comparison
BHC vs LMAT Comparison
Compare BHC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- LMAT
- Stock Information
- Founded
- BHC N/A
- LMAT 1983
- Country
- BHC Canada
- LMAT United States
- Employees
- BHC N/A
- LMAT N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- BHC Health Care
- LMAT Health Care
- Exchange
- BHC Nasdaq
- LMAT Nasdaq
- Market Cap
- BHC 2.3B
- LMAT 1.9B
- IPO Year
- BHC N/A
- LMAT 2006
- Fundamental
- Price
- BHC $6.85
- LMAT $84.06
- Analyst Decision
- BHC Hold
- LMAT Buy
- Analyst Count
- BHC 5
- LMAT 6
- Target Price
- BHC $7.20
- LMAT $100.80
- AVG Volume (30 Days)
- BHC 3.0M
- LMAT 156.3K
- Earning Date
- BHC 07-31-2025
- LMAT 07-31-2025
- Dividend Yield
- BHC N/A
- LMAT 0.95%
- EPS Growth
- BHC N/A
- LMAT 30.45
- EPS
- BHC N/A
- LMAT 1.97
- Revenue
- BHC $9,731,000,000.00
- LMAT $226,256,000.00
- Revenue This Year
- BHC $3.71
- LMAT $13.88
- Revenue Next Year
- BHC $5.03
- LMAT $8.81
- P/E Ratio
- BHC N/A
- LMAT $42.77
- Revenue Growth
- BHC 8.53
- LMAT 13.19
- 52 Week Low
- BHC $3.96
- LMAT $71.42
- 52 Week High
- BHC $9.85
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- BHC 78.05
- LMAT 50.08
- Support Level
- BHC $6.38
- LMAT $80.86
- Resistance Level
- BHC $6.81
- LMAT $83.72
- Average True Range (ATR)
- BHC 0.31
- LMAT 1.97
- MACD
- BHC 0.09
- LMAT 0.13
- Stochastic Oscillator
- BHC 91.29
- LMAT 53.46
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.